ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CTXR Citius Pharmaceuticals Inc

0.6699
-0.0627 (-8.56%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2021Sep 2021Dec 2021Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0000003.59M0
Operating Income -6.6M-5.2M-9.26M-13.45M-7.25M-10.69M-5.09M-10.13M
Pre Tax Income -7.28M-3.51M-9.23M-13.32M-3.45M-10.38M-8.34M-9.8M
Net Income -7.28M-3.51M-9.23M-13.89M-3.59M-10.24M-8.77M-11.1M
Preferred Dividends 0000000-1.15M
Basic Earnings Per Share (EPS) 00000000
EBIT -7.99M-5.04M-9.26M-13.45M-3.67M-10.69M-5.09M-6.54M
EBITDA -6.48M-5.33M-9.26M-13.58M-7.2M-10.73M-4.94M-10.27M
Year End September 29 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -7.45M-9.99M-13.79M-15.6M-17.71M-23.53M-39.22M-36.73M
Pre Tax Income -8.3M-10.39M-12.54M-15.56M-17.55M-23.05M-38.97M-31.97M
Net Income -8.3M-10.39M-12.54M-15.56M-17.55M-23.05M-39.54M-33.69M
Preferred Dividends 0000000-1.15M
Basic Earnings Per Share (EPS) -0.243-2.13-1.502-0.538-0.316-0.158-0.271-0.212
EBIT -7.45M-9.99M-12.52M-15.6M-17.6M-23.31M-39.22M-33.15M
EBITDA -7.45M-9.98M-13.79M-15.6M-17.71M-23.53M-39.21M-36.73M

Your Recent History

Delayed Upgrade Clock